Your browser doesn't support javascript.
loading
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses.
Ibi, Dorina; Boot, Manon; Dollé, Martijn E T; Jukema, J Wouter; Rosendaal, Frits R; Christodoulides, Constantinos; Neville, Matt J; Koivula, Robert; Rensen, Patrick C N; Karpe, Fredrik; Noordam, Raymond; Willems van Dijk, Ko.
Afiliación
  • Ibi D; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Public Health and Primary Care, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Electronic address: d.ibi@lumc.nl.
  • Boot M; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Dollé MET; Department of Public Health and Primary Care, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Netherlands Heart Institute, Utrecht, The Netherlands.
  • Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Christodoulides C; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Neville MJ; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals Foundation Trust, Oxford, United Kingdom.
  • Koivula R; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Rensen PCN; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Karpe F; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals Foundation Trust, Oxford, United Kingdom.
  • Noordam R; Division of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Willems van Dijk K; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, L
J Lipid Res ; 63(5): 100193, 2022 05.
Article en En | MEDLINE | ID: mdl-35278410
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Apolipoproteína A-V Límite: Humans Idioma: En Revista: J Lipid Res Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Apolipoproteína A-V Límite: Humans Idioma: En Revista: J Lipid Res Año: 2022 Tipo del documento: Article